PTBA:IDXPT Bukit Asam (Persero) Tbk Analysis
Data as of 2026-09-01 - not real-time
IDR 2,750.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At IDR 2,750.00, PT Bukit Asam (Persero) Tbk shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 14.1%. Relative strength is 79.1 — overbought — and the MACD signal is bullish. The recent range runs from support at IDR 2,310.00 up to resistance at IDR 2,790.00.
On valuation the read is undervalued — earnings multiple of 9.5 versus a 21.6 sector average, below the peer group. Analyst price targets sit 10.6% above the current price. The 4.47% dividend yield looks stretched against payout coverage.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 29.2%, a beta of -0.08 and a maximum drawdown of 28.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
On valuation the read is undervalued — earnings multiple of 9.5 versus a 21.6 sector average, below the peer group. Analyst price targets sit 10.6% above the current price. The 4.47% dividend yield looks stretched against payout coverage.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 29.2%, a beta of -0.08 and a maximum drawdown of 28.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Top Market Events
Langkah ini merupakan tindak lanjut atas ketentuan Undang-Undang Nomor 19 Tahun 2003 tentang Badan Usaha Milik Negara.KONTAN.CO.ID – JAKARTA. PT Bukit Asam Tbk PTBA telah mengantongi persetujuan Rencana Kerja dan Anggaran Biaya RKAB...PT Bukit Asam Tbk shares on the Indonesia Stock Exchange closed lower on 06/01/2026, with trading da
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- RSI at 79.1 signals overbought conditions
- Trading above the 200-day average of 2564.10
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- RSI at 79.1 signals overbought conditions
- P/E of 9.5 versus sector average of 21.6
- Dividend yield of 4.47% looks stretched against payout coverage
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 9.5 versus sector average of 21.6
- Dividend yield of 4.47% looks stretched against payout coverage
- Analyst targets imply +10.6% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-0.30%
Profit Margin7.84%
P/E Ratio9.5
ROE14.41%
ROA5.27%
Debt/Equity11.49
P/B Ratio1.3
Op. Cash FlowIDR7108.0B
Free Cash FlowIDR488.1B
Industry P/E21.6
Technical Analysis
TrendNeutral
RSI79.1
SupportIDR 2,310.00
ResistanceIDR 2,790.00
MA 20IDR 2,416.50
MA 50IDR 2,393.80
MA 200IDR 2,564.10
MACDBullish
VolumeIncreasing
Fear & Greed Index94.55
Valuation
Fair ValueIDR 706.41
Target PriceIDR 3,042.14
Upside/Downside10.62%
GradeUndervalued
TypeValue
Dividend Yield4.47%
Risk Assessment
Beta-0.08
Volatility29.19%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.